We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

No waffle here

24 March 2005 By Robert Cyran

Even without costcuts, the purchase will give a good return on investment. Throw in some synergies, and this looks like an excellent deal. The Belgian chemical and drug group is the latest acquirer in the continuing consolidation of Europe s drug makers.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)